![Thor Low Volatility ETF](/common/images/company/NY_THLV.png)
Broad Protection of Namodenoson is expected till at least 2044 PETACH TIKVA, Israel, July 29, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a...
RAMAT GAN, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
PETACH TIKVA, Israel, July 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule...
Liver cirrhosis treatment global market is estimated to reach $29.2 billion by 2030 Ramat Gan, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF...
The canine osteoarthritis market is projected to reach $3 billion by 2028 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0394 | -0.144114355107 | 27.3394 | 27.43 | 26.9771 | 7552 | 27.17540003 | SP |
4 | 0.438 | 1.63055617601 | 26.862 | 27.6884 | 26.588 | 6523 | 27.1104273 | SP |
12 | 0.78 | 2.94117647059 | 26.52 | 27.6884 | 26.44 | 6607 | 26.95122319 | SP |
26 | 2.04 | 8.07600950119 | 25.26 | 27.6884 | 25.19 | 8534 | 26.55849674 | SP |
52 | 1.2 | 4.59770114943 | 26.1 | 27.6884 | 23.77 | 18156 | 25.13405275 | SP |
156 | 1.7099 | 6.68188088362 | 25.5901 | 27.6884 | 23.38 | 27223 | 24.96942466 | SP |
260 | 1.7099 | 6.68188088362 | 25.5901 | 27.6884 | 23.38 | 27223 | 24.96942466 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.